I, Ashley Woodcock, residing in United Kingdom of Great Britain and Northern Ireland, a Co-chair of the Technology and Economic Assessment Panel (TEAP) and Member of the Medical and Chemicals Technical Options Committee declare as follows:

1. I have read the Conflict of Interest and Disclosure Guidelines for the Technology and Economic Assessment Panel, Its Technical Options Committees and Temporary Subsidiary Bodies (“the COI Guidelines”) as adopted by the Meeting of the Parties in Decision XXIV/8.
2. I am Professor of Respiratory Medicine at University of Manchester, and Consultant Physician at the Manchester University NHS Foundation Trust. I am Chairman of Axalbion and Board Member for Reacta Healthcare neither of which have related activities to the Montreal Protocol. I am a voluntary Trustee the British Medical Association Foundation and the North West Lung Centre Charity, and Advisor to the JP Moulton Charity, none of which have activities related to the Montreal Protocol I have received an honorarium from GlaxoSmithKline in Sept 2025 for participating in an education session on "Green inhalers".
3. This declaration constitutes my written agreement, pursuant to paragraph 8 of the COI Guidelines, to comply with the Guidelines. I understand that this written agreement is a condition of my service.
4. My interests, and those of my personal partner and dependents include the following
   • Proprietary interests: I do not have proprietary interest in substance, technology or process to be considered by TEAP or any TOC or any temporary subsidiary body.
   • Financial interests: I do not have ownership, shares or bonds in an entity with an interest in the subject matter of the meeting or work.
   • Employment, consultancy, directorship or other positions: I am Chairman of Axalbion and Board Member for Reacta Healthcare neither of which have related activities to the Montreal Protocol. I am a voluntary Trustee the British Medical Association Foundation and the North West Lung Centre Charity, and Advisor to the JP Moulton Charity, none of which have activities related to the Montreal Protocol I have received an honorarium from GlaxoSmithKline in Sept 2025 for participating in an education session on "Green inhalers".
   • Government advice and other policy development: None
   • Paid research activities, fellowships or grants: None
   • Other interests: None
5. The source of travel funding for my participation in the work of TEAP is the University of Manchester and Manchester University NHS Foundation Trust.
6. Pursuant to paragraph 11 of the COI Guidelines, I declare that I have not declined to disclose information falling within paragraph 10 of those Guidelines.
7. I undertake to disclose any material change to any of the above information, pursuant to paragraph 9 of the COI Guidelines, within 30 days of any such change.
8. I undertake to make further declarations of interest annually for so long as I remain a member of the TEAP body.
9. I understand that this DOI will expire on 31 December 2026 after I have signed it.

Signed: Ashley Woodcock
Date: 2026-01-08